Herborium® Group And Kamasutra (USA) LLC Debut Kamasutra™ Exotic Vodka with Natural Herbs In The USA , At Buy-Rite In New Jersey Press Release: Herborium Group, Inc.

FORT LEE, N.J., Aug. 9, 2012 /PRNewswire/ -- Herborium Group, Inc., (HBRM) www.herborium.com, a Botanical Therapeutics® Company, is pleased to announce that Kamasutra™ Exotic Vodka with Natural Herbs provided by Herborium, a pioneering specialty drink now available for the first time in the US, will be unveiled  today at the largest Buy-Rite store in New Jersey.  Super Buy-Rite is the largest liquor store in the state of New Jersey, with over 30,000 square feet of retail space and a part of one of the largest liquor store franchises in New Jersey.

Kamasutra™ is the first-ever alcoholic beverage creation developed and endorsed by herbaceutical science and will appeal to a wider segment of experimental, progressive adult beverage drinkers that represent a rapidly growing segment of the $4 billion US market for flavor vodka.

"We are convinced that this product is destined to be a great success," commented Dr. Agnes P. Olszewski, CEO of Herborium. "From the proprietary herbal formula that we have developed  specially for this product, through its much lighter taste, at only 25% alcohol, and its unique bottle shape that brings the product to life , Kamasutra™ Exotic Vodka With Natural Herbs brings the best of natural lifestyle to discriminating adult customers," continues Dr. Olszewski.

"With this first step in a commercialization process that will bring the product into all states in the US, we are lucky to be a part of a very talented and experienced group lead by Tom Wilen with his decades of the most successful track record in alcoholic beverage industry, and including between others Michael Barsella, President of BonFun Wine, LLC.  I am absolutely sure they will make this project a market and financial success," concluded Dr. Olszewski.

About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sells its products in the US and Europe. For more information, please visitwww.herborium.com and www.acnease.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com